InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the full record of transactions filed by Ciaffoni Joseph, Chairman & CEO. Officer active across 2 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 10 disclosures have been recorded. Total volume traded: €1.1m. The latest transaction was filed on 1 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
€1m65,083 shares@ €16.37850.073% mcap77.3% of flow
Common Stock
SEC:0001062993-22-006644:0·
0125,000 shares0
Common Stock
SEC:0001062993-22-004320:0·
€17,9021,090 shares@ €16.42420.0012% mcap11.5% of flow
Common Stock
SEC:0001879789-22-000001·
€17,9021,090 shares@ €16.42420.0012% mcap1.3% of flow
Common Stock
SEC:0001879789-22-000001:0·
€22,4981,386 shares@ €16.23260.0015% mcap14.4% of flow
Common Stock
SEC:0001192482-21-000661·
€22,4981,386 shares@ €16.23260.0015% mcap1.6% of flow
Common Stock
SEC:0001192482-21-000661:0·
€28,2301,394 shares@ €20.25120.0019% mcap18.1% of flow
Common Stock
SEC:0001192482-21-000623·
€28,2301,394 shares@ €20.25120.0019% mcap2.0% of flow
Common Stock
SEC:0001192482-21-000623:0·
€87,5684,672 shares@ €18.74320.0060% mcap56.1% of flow
Common Stock
SEC:0001192482-21-000479·
€87,5684,672 shares@ €18.74320.0060% mcap6.4% of flow
Common Stock
SEC:0001192482-21-000479:0·
10 of 10 declarations
About Ciaffoni Joseph
Joseph Ciaffoni is the President and CEO of Collegium Pharmaceutical, Inc. He is responsible for the strategic and operational direction of the company. Ciaffoni plays a key role in implementing new initiatives and optimizing performance. His experience in the pharmaceutical sector is an asset for Collegium.